创新药概念继续走强 金斯瑞生物科技(01548)涨6.87% 机构指中国创新药全球地位持续提升

金吾财讯
Yesterday

金吾财讯 | 港股创新药概念持续走强,截至发稿,金斯瑞生物科技(01548)涨6.87%,再鼎医药(09688)涨5.51%,同源康医药-B(02410)涨4.81%,晶泰控股(02228)涨3.94%,药明合联(02268)涨3.92%,翰森制药(03692)涨3.76%,亚盛医药(06855)涨3.63%,百济神州(06160)涨3.38%,药明康德(02359)涨3.03%,诺诚健华(09969)涨2.83%,石药集团(01093)涨2.78%。消息面上,国金证券研究指,创新药企业扭亏节点到来,全年临床数据催化密集,叠加已BD出海管线海外临床进展顺利,看好创新药板块投资机会。具体布局思路而言:(1)布局业绩财报窗口期,掘金业绩超预期标的;(2)关注学会大会动态,把握重磅临床数据发布窗口;(3)聚焦核心赛道,持续关注小核酸、双抗、ADC等相关标的的投资机会,把握产业兑现期的红利行情。国元国际证券亦表示,出海交易量价齐升,中国创新药全球地位持续提升。中国创新药出海持续超预期,上半年997亿美元的交易总额和全球TOP10中独占8席的成绩,充分验证了中国创新药资产的全球竞争力。叠加海外融资全面回暖、外需明显改善,看好创新药的出海前景。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10